Hulic RE, Hisamitsu Pharmaceuticals, etc. (additional) Rating

Target Price Change Code Stock Name Securities Company Previous After---------------------------------------------------<2337> Ichigo SMBC Nikko 420 yen 430 yen <2579> Coca BJH Mizuho 2550 yen 2750 yen <3087> Doutor Nihon Res Morgan S 2500 yen 2700 yen <3295> Hulic RE Nomura 149000 yen 157000 yen <4530> Hisamitsu Pharma Mizuho 4700 yen 4850 yen <4

Fisco JapanApr 22 10:37

Rating information (Target Price Change - Part 1) = Daifuku, Ichigo ETC.

◎ Daiwa Securities (5 levels: 1>2>3>4>5) Daifuku <6383.T> --- "2"→"2", 3400 yen→4200 yen Torii Pharmaceutical <4551.T> --- "3"→"3", 3800 yen→4200 yen ◎ SMBC Nikko Securities (3 levels: 1>2>3) Ichigo <2337.T> --- "2"→"2", 420 yen→430 yen ◎ Mizuho Securities (3 levels: Buy>Hold>underperform) Sanyo Chemical <4471.T> --- "Buy"→"Buy", 5000 yen→4500 yen Hotonic

Kabushiki ShimbunApr 22 08:54

List of cloud penetration stocks [Ichimoku Kinko Hyo - List of cloud penetration stocks]

○ List of stocks breaking through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1333> Maruha Nichiro 3142 3111.25 3082 <1720> Tokyu Construction 7747 70.5751 <1879> Shin-Nihon Kensei 1527 1489.5 1507 <1925> Daiwa House 4993 49634843.5 <1926> Light Industry 2492 2487.25 2425 <200

Fisco JapanApr 15 06:48

List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]

○ List of stocks that have changed to Buy market Code Stock Name Closing Price SAR Main Board <1803> Shimizu Corporation 1335 1167 <1879> Shin Nihon Kan 1490 1311 <1885> Toa Construction 1244 1067 <1890> Toyo Construction 1304 1137 <1899> Fukuda Group 4995 4375 <1938> Nichiritech 1469 1262 <1941> Chudenko 3280 2882 <1949> Sumitomo

Fisco JapanApr 14 06:40

April 11th [Today's Investment Strategy]

[Fisco Selected Stocks] 【Material Stocks】 Beikaren <6532> 6,757 yen (4/10) provides Consulting Services. Announced financial results for the fiscal year ending February 2025. Operating profit is 42.6 billion yen (24.5% increase compared to the previous period). The operating profit for the fiscal year ending February 2026 is estimated at 51 billion yen (19.7% increase compared to the previous period). At the same time, the basic policy for shareholder returns has been partially revised, setting a dividend payout ratio at 40% on an IFRS basis, and regarding annual surplus cash, focusing on Share Buyback for shareholder returns.

Fisco JapanApr 11 08:11

Focusing on Warabe Nichiyo and Beikarebento, while Tama Home and Alenza HD appear weak.

In the U.S. stock market on the 10th, the Dow Jones Industrial Average fell by $1,014.79 to $39,593.66, the Nasdaq Composite Index dropped by 737.66 points to 16,387.31, and the Chicago Nikkei 225 Futures declined by 1,240 to ¥33,400 compared to Osaka during the day. The exchange rate is 1 dollar = 144.40-50 yen. In today's Tokyo market, Hisamitsu Pharmaceutical Co., Ltd. <4530>, which had a Financial Estimates operating profit increase of 43.5%, exceeding the previous estimate of a 36.7% increase, has an operating profit projected to increase by 24.5% for the previous period and 19.7% for the current period, leading to shareholder returns.

Fisco JapanApr 11 07:15

Hisamitsu Pharmaceutical To Go Ex-Dividend On February 26th, 2026 With 45 JPY Dividend Per Share And 15 JPY Special Dividend Per Share

April 11th (Japan Standard Time) - $Hisamitsu Pharmaceutical(4530.JP)$ is trading ex-dividend on February 26th, 2026.Shareholders of record on February 28th, 2026 will receive 45 JPY dividend per

Futu NewsApr 11 05:25

Hisamitsu Pharmaceutical To Go Ex-Dividend On August 28th, 2025 With 45 JPY Dividend Per Share And 15 JPY Special Dividend Per Share

April 11th (Japan Standard Time) - $Hisamitsu Pharmaceutical(4530.JP)$ is trading ex-dividend on August 28th, 2025.Shareholders of record on August 31st, 2025 will receive 45 JPY dividend per share

Futu NewsApr 11 05:25

Fast Retailing, on August 25, upwardly revised operating profit to 545 billion yen from 530 billion yen.

Fast Retailing <9983> announced a revision of its financial forecasts for the fiscal year ending August 2025. The operating profit was revised upward from 530 billion yen to 545 billion yen. In the second quarter, the overseas Uniqlo business reported sales revenues of 1 trillion 14.1 billion yen, a 14.7% increase compared to the same period last year, and operating profit of 168.5 billion yen, an increase of 11.7%, marking a significant increase in both revenue and profit. Support for Uniqlo's core commodities is rising globally, allowing continued expansion of performance. In China, both revenue and profits have decreased. [Positive assessment] <3662> Ateam HD revision|

Fisco JapanApr 11 05:18

Key points of interest for PTS on the 10th = Fast Retailing, Haseko, Timee, ETC.

▽ Fast Retailing <9983.T> revised the Financial Estimates for consolidated operating profit for the fiscal year ending August 2025 from 530 billion yen to 545 billion yen (an increase of 8.8% compared to the previous fiscal year). Furthermore, the annual Dividends forecast has been increased from 450 yen to 480 yen (the previous year was 400 yen). ▽ Nagase & Co. <1808.T> has initiated a public tender offer for Wood F <8886.T>. ▽ Timee <215A.T> has formed a business partnership with a subsidiary of Watami <7522.T>. ▽ Part-time Job T <2341.T> has announced its financial results for the fiscal year ending February 2025.

Kabushiki ShimbunApr 10 15:53

Hisamitsu Pharmaceutical Announces Board of Directors Candidates

TipRanksApr 10 15:01

Hisamitsu Pharmaceutical Reports Strong Fiscal Year 2025 Results and Announces Commemorative Dividends

TipRanksApr 10 15:00

Express News | Hisamitsu 2024/25 Group Recurring Profit 24.01 Bln Yen (+22.2 %), 2025/26 Forecast Profit 24.30 Bln Yen (+1.2 %)

BreakingsApr 10 14:30

Express News | Hisamitsu 2024/25 Group Operating Profit 18.90 Bln Yen (+43.5 %), 2025/26 Forecast Profit 20.00 Bln Yen (+5.8 %)

BreakingsApr 10 14:30

Hisamitsu Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending February 2025 [Japanese GAAP] (Consolidated)

JPXApr 10 14:30 · Announcements

Hisamitsu Pharmaceutical Sees FY Net Y22.00B

Dow JonesApr 10 14:30

San-Ai, Next Stage, WNI Weather, Yakukodo HD (7th)

※The above Calendar is subject to change due to the company's circumstances.---------------------------------------April 7 (Monday) <2659> San-A <2734> Sara <2789> Karura <3148> Create SD <3186> Nextage <4825> WNI Weather <7679> Yakuodo HD <8923> Tosei<

Fisco JapanApr 7 05:30

Hisamitsu Pharmaceutical invests in the startup company ORPHE.

On the 27th, Hisamitsu Pharmaceutical <4530.T> announced it has invested in the third-party allocation of shares for the startup company ORPHE (Shibuya, Tokyo). ORPHE is a company engaged in walking analysis DX (digital transformation) business for medical and Health Care sectors. It has developed sensing solutions that digitize foot movements, enabling high-precision walking analysis by measuring walking from various aspects. The company aims to grow ORPHE's business through this investment.

Kabushiki ShimbunMar 28 07:29

Jukoh Pharmaceutical shows slight movement as it formulates its basic cash allocation policy.

The largest manufacturer of pain-relieving and anti-inflammatory adhesive patches, Hishukai Pharmaceutical <4530.T>, has been quiet. At one point, the stock rose by 54 yen from the previous day to reach 4,165 yen. After the market closed on the 10th, the company announced the formulation of fundamental policies regarding cash allocation. Over the five years from the fiscal year ending February 2027 to the fiscal year ending February 2031, the company plans to invest 200 billion yen in growth investments (capital investment, strategic investment, research and development) and return more than 50 billion yen to shareholders (dividends, share buybacks). This aims to accelerate business growth and improve capital profitability. On this day, the market was broadly down.

Kabushiki ShimbunMar 11 09:05

Hisamitsu Pharmaceutical To Go Ex-Dividend On February 27th, 2025 With 43 JPY Dividend Per Share And 2 JPY Special Dividend Per Share

February 26th (Japan Standard Time) - $Hisamitsu Pharmaceutical(4530.JP)$ is trading ex-dividend on February 27th, 2025.Shareholders of record on February 28th, 2025 will receive 43 JPY dividend per

Futu NewsFeb 26 09:00